[188 Pages Report] Antibiotic susceptibility testing market revenue totaled US$ 2.82 Billion in 2021. The global market is expected to reach a valuation of US$ 4.05 Billion by 2028, expanding at a CAGR of 5.2%.
| Antibiotic Susceptibility Testing Market Size (2022) | US$ 3 Billion |
|---|---|
| Sales Forecast (2028) | US$ 4.05 Billion |
| Global Market Growth Rate (2022 to 2028) | 5.2% CAGR |
| Share of Top 5 Market Players | 50% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 5.64% |
| H1, 2022 Projected | 5.16% |
| H1, 2022 Outlook | 4.66% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 50 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (-) 98 ↓ |
The global antibiotic susceptibility testing market is subject to changes as per the macro and industrial dynamics associated with the drug and device regulations, product licensing, and product distribution.
Key developments in the market include the development of novel MALDI-TOF mass spectrometry for the rapid identification of disease pathogens or causative bacterial organisms.
H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 50 BPS. However, In H1-2022, the market growth rate of antibiotic susceptibility testing is expected to fall by 98 basis point share (BPS), as per FMI analysis.
The drop in the BPS values is associated with the complicated pre-analytical process associated with antibiotic susceptibility testing thus presenting a high procedural cost. Moreover, the necessity for a comparatively vast quantity of viable organisms, and a limited database spectrum for micro-organisms has presented a hurdle in the growth of the market, thus resulting in the reduced BPS values.
However, the expected introduction of microfluidics and microdroplets for antibiotic susceptibility testing will present a positive growth outlook for the market over the forecasted years.
“Increasing Awareness Initiatives about Antibiotic Resistance to Boost Demand for Antibiotic Susceptibility Testing”
From 2013 to 2021, the global antibiotic susceptibility testing market progressed at a CAGR of around 5.5%.
Antibiotic susceptibility testing is performed as a routine to ensure the efficient use of antibiotics. It determines the lowest concentrations of new or existing antimicrobial agents and inhibits consistent and visible growth of the bacterium that is being investigated, under specific test conditions.
It is the detection of possible drug resistance in some of the most common pathogens and the discovery of susceptibility of the drugs of choice for particular infections.
Constant advancements in instruments used for antibiotic susceptibility testing have led to gaining FDA clearance for these systems.
Modifications in antibiotic susceptibility testing instruments include improvements in the computer software for either providing an extended incubation period for difficult organism-drug combinations or, by using expert software to edit susceptibility test results for prevention of unwanted results from being noted.
The global antibiotic susceptibility testing market is anticipated to expand at a 5.2% CAGR from 2022 to 2028.
“Advancements in Rapid AST Methods & Instruments to Fuel Market Expansion”
Rapid AST methods enable targeted therapy for any treatment, as early as possible. Growing advancements in AST methods are expected to boost the market growth for antibiotic susceptibility testing during the forecast period.
Widespread usage of online channels is responsible for a consistent and rapid increase in the sales of antibiotic susceptibility testing systems in recent years. Vendors operating in the antibiotic susceptibility testing market are focusing on online marketing and promotional strategies to increase sales and ensure better access to their devices.
Online platforms enable vendors to offer information about the devices in their portfolios as well as gain access to local as well as global markets. In addition, online marketing websites offer a wide selection of branded AST methods at affordable costs and attractive discounts.
“Complex Regulatory Framework Major Restraining Factor for Market Growth”
Automated antibiotic susceptibility testing tools are costly as they come with several complex features and functions. Incubation and detection times are cut by 50% when automated AST methods are resorted to. This factor is a major hurdle to their widespread acceptance by end users, particularly smaller medical facilities.
Furthermore, scientific and regulatory challenges faced by businesses in the market extend the time to market and raise development costs, thereby compromising product marketability. The market is likely to be restrained by tight regulatory government policies and the hurdles involved with antimicrobial susceptibility testing.
Principal Consultant
“Ongoing Advancements in Antibiotic Resistance Testing Systems”
North America is expected to lead the global antibiotic susceptibility testing market in terms of market value, accounting for nearly 28.6% share in the global market.
Growing adoption of antibiotic susceptibility testing in a medical laboratory, rising research and development activities for antibiotic resistance testing systems, and increased demand for antibiotic susceptibility testing to support empiric treatment is driving market growth in North America.
Most well-known corporations are based in the region. Key players have concentrated on expansion to broaden their network and capacities. These factors are driving market expansion across the continent.
Why is the Antibiotic Susceptibility Testing Market in the U.S. Growing at Rapid Pace?
“Increased Prevalence of Infectious Diseases to Augment Demand for Antimicrobial Susceptible Test Products”
The market in the U.S. is likely to expand at a rapid pace over the forecast period, because of the rising prevalence of drug-resistant contagious diseases, a very well healthcare system, a favorable government environment, and rising R&D expenditure.
The excellent technical ability of market players has a significant impact on technological advancements of antimicrobial susceptible test products. Public health, as the top priority, has been demonstrated to have a favorable impact on public-private partnerships in the United States.
This is also expected to be used as a tool to help market players improve the pace of antimicrobial susceptible test product development.
“Surge in Funding for Development of Antibiotic Sensitivity Testing”
Growing concerns among people about their wellness and increasing use of over-the-counter antibiotics are driving market expansion in China. Rise in funding for the advancement of antibiotic sensitivity testing procedures is another important aspect for market expansion.
Increasing adoption of minimum inhibitory concentration in antibiotic sensitivity testing performed in a clinical lab, as well as increased antibiotic-resistant awareness activities, are driving market growth in China.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Which Antibiotic Susceptibility Testing Product is Projected to Gain Traction?
“Manual Broth Microdilution System Most Preferred Attributed to Low Cost & Easy Handling Techniques”
Susceptibility testing discs, MIC strips, and susceptibility testing plates are all manual broth microdilution systems. The demand for manual broth microdilution systems is being driven by an increase in antibiotic resistance, new product introductions, and the adoption of susceptibility testing discs.
Growing acceptance of the disc diffusion technique and improvements in susceptibility plates are driving the demand for manual broth microdilution systems. Moreover, manual products offer flexibility and cost savings through the use of technologies such as disc diffusion and gradient diffusion.
Due to an increase in demand for particular susceptibility testing systems to define the scope of targeted therapy, sales of manual broth microdilution system equipment will see healthy growth.
“Hospitals to Remain Primary End User Due to Enhanced Health Coverage Plans”
Antibiotic testing is performed in hospitals to a large extent with the latest technologies available, therefore hospitals are projected to dominate the market. Antibiotic susceptibility testing aids in the assessment of hospital-based treatment services.
The need for antibiotic susceptibility testing kits is increasing as a result of the recent shift toward individualized treatments. The large share of this segment is mainly attributed to the presence of a well-equipped facility and qualified professionals, the increase in hospital-acquired infectious diseases, and key companies' initiatives to sell antibiotic susceptibility testing products through hospitals.
The COVID-19 pandemic has had a negative impact on the market, lowering demand and sales. This was owing to the cancellation of antibiotic susceptibility testing, as well as delays in clinical studies, supply chain concerns, and decreased sales and marketing activities.
Because market players have limited access to present and potential clients, they have been unable to complete sales of new antibiotic susceptibility testing systems or install previously sold systems, limiting the expansion of consumable test kits.
Now, due to improved healthcare systems, rise in unfulfilled healthcare demands, and increase in the occurrence of antibiotic resistance in individuals, there are lucrative growth opportunities awaiting antibiotic susceptibility testing system manufacturers.
Leading market players have upgraded their manufacturing facilities and are engaged in a variety of R&D activities. Regulatory approvals, high-tech products, introduction of new products, acquisitions, and collaborative partnerships with other companies are all priorities for key providers of antibiotic susceptibility testing systems.
For instance,
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2028 |
| Historical Data Available for | 2013 to 2021 |
| Market Analysis | Value in US$ Million |
| Key Regions Covered |
|
| Key Countries Covered |
|
| Key Market Segments Covered |
|
| Key Companies Profiled |
|
| Pricing | Available upon Request |
Antibiotic Susceptibility Testing Market by Product:
Antibiotic Susceptibility Testing Market by Application:
Antibiotic Susceptibility Testing Market by End User:
Antibiotic Susceptibility Testing Market by Region:
Rising prevalence of testing in hospitals and diagnostics for providing appropriate therapies to patients is driving market growth.
Major companies supplying antibiotic susceptibility testing systems include BD, Danaher, Thermo Fisher Scientific, Bio-Rad, and Creative Diagnostics.
The global antibiotic susceptibility testing market is estimated to exhibit a CAGR of 5.2% during the forecast period (2022-2028).
North America accounts for 28.6% share of the global antibiotic susceptibility testing market.
The global market for antibiotic susceptibility testing is expected to reach a valuation of US$ 4.05 Bn by 2028.
1. Executive Summary 1.1. Market Overview 1.2. Market Analysis 1.3. FMI Analysis and Recommendations 1.4. Wheel of Fortune 2. Market Introduction 2.1. Market Definition 2.2. Market Taxonomy 3. Global Market Opportunity Analysis 3.1. Macro-Economic Factors 3.2. Opportunity Analysis 4. Global Economic Outlook 4.1. Global Gross Domestic Product by Region & Country, 2013 – 2021 4.2. Healthcare Sector Outlook by Region & Country, 2013 – 2021 5. Key Inclusions 5.1. Development Roadmap for Systems 5.2. Technology Assessment 6. Market Background 6.1. Market Dynamics 6.1.1. Drivers 6.1.2. Restraints 6.1.3. Trends 7. North America Market Analysis 2013-2021 and Forecast 2022–2028 7.1. Introduction 7.2. Historical Market Size Analysis By Country, 2013-2021 7.2.1. U.S. 7.2.2. Canada 7.3. Market Size Forecast By Country, 2022–2028 7.3.1. U.S. 7.3.2. Canada 7.4. Historical Market Size Forecast By Product Type, 2022–2028 7.4.1. Instruments 7.4.1.1. Automated Broth Microdilution Systems 7.4.1.2. Manual Broth Microdilution Systems 7.4.1.3. Semi-Automated Broth Microdilution Systems 7.4.2. Software & Services 7.4.2.1. Image Analysis Software 7.4.2.2. Installation Services 7.4.3. Kits & Reagents 7.5. Market Size Forecast By Product Type, 2022–2028 7.6. Historical Market Size Forecast By Application, 2022–2028 7.6.1. Sepsis 7.6.2. Respiratory Infections 7.6.3. Gastrointestinal Infections 7.6.4. Meningitis & Encephalitis 7.6.5. Endocarditis 7.6.6. Others 7.7. Market Size Forecast By Application, 2022–2028 7.8. Historical Market Size Forecast By End User, 2022–2028 7.8.1. Diagnostic Laboratories 7.8.2. Hospitals 7.8.3. Research Laboratories 7.9. Market Size Forecast By End User, 2022–2028 7.10. Market Attractiveness Analysis 7.10.1. By Country 7.10.2. By Product Type 7.10.3. By Application 7.10.4. By End User 8. Latin America Market Analysis 2013-2021 and Forecast 2022–2028 8.1. Introduction 8.2. Historical Market Size Analysis By Country, 2013-2021 8.2.1. Brazil 8.2.2. Mexico 8.2.3. Rest of Latin America 8.3. Market Size Forecast By Country, 2022–2028 8.4. Historical Market Size Forecast By Product Type, 2022–2028 8.4.1. Instruments 8.4.1.1. Automated Broth Microdilution Systems 8.4.1.2. Manual Broth Microdilution Systems 8.4.1.3. Semi-Automated Broth Microdilution Systems 8.4.2. Software & Services 8.4.2.1. Image Analysis Software 8.4.2.2. Installation Services 8.4.3. Kits & Reagents 8.5. Market Size Forecast By Product Type, 2022–2028 8.6. Historical Market Size Forecast By Application, 2022–2028 8.6.1. Sepsis 8.6.2. Respiratory Infections 8.6.3. Gastrointestinal Infections 8.6.4. Meningitis & Encephalitis 8.6.5. Endocarditis 8.6.6. Others 8.7. Market Size Forecast By Application, 2022–2028 8.8. Historical Market Size Forecast By End User, 2022–2028 8.8.1. Diagnostic Laboratories 8.8.2. Hospitals 8.8.3. Research Laboratories 8.9. Market Size Forecast By End User, 2022–2028 8.10. Market Attractiveness Analysis 8.10.1. By Country 8.10.2. By Product Type 8.10.3. By Application 8.10.4. By End User 9. Europe Market Analysis 2013-2021 and Forecast 2022–2028 9.1. Introduction 9.2. Historical Market Size Analysis By Country, 2013-2021 9.2.1. United Kingdom 9.2.2. France 9.2.3. Italy 9.2.4. Spain 9.2.5. Russia 9.2.6. Germany 9.2.7. Rest of Eastern Europe 9.3. Market Size Forecast By Country, 2022–2028 9.4. Historical Market Size Forecast By Product Type, 2022–2028 9.4.1. Instruments 9.4.1.1. Automated Broth Microdilution Systems 9.4.1.2. Manual Broth Microdilution Systems 9.4.1.3. Semi-Automated Broth Microdilution Systems 9.4.2. Software & Services 9.4.2.1. Image Analysis Software 9.4.2.2. Installation Services 9.4.3. Kits & Reagents 9.5. Market Size Forecast By Product Type, 2022–2028 9.6. Historical Market Size Forecast By Application, 2022–2028 9.6.1. Sepsis 9.6.2. Respiratory Infections 9.6.3. Gastrointestinal Infections 9.6.4. Meningitis & Encephalitis 9.6.5. Endocarditis 9.6.6. Others 9.7. Market Size Forecast By Application, 2022–2028 9.8. Historical Market Size Forecast By End User, 2022–2028 9.8.1. Diagnostic Laboratories 9.8.2. Hospitals 9.8.3. Research Laboratories 9.9. Market Size Forecast By End User, 2022–2028 9.10. Market Attractiveness Analysis 9.10.1. By Country 9.10.2. By Product Type 9.10.3. By Application 9.10.4. By End User 10. APAC Market Analysis 2013-2021 and Forecast 2022–2028 10.1. Introduction 10.2. Historical Market Size Analysis By Country, 2013-2021 10.2.1. Japan 10.2.2. China 10.2.3. India 10.2.4. Australia 10.2.5. Rest of APAC 10.3. Market Size Forecast By Country, 2022–2028 10.4. Historical Market Size Forecast By Product Type, 2022–2028 10.4.1. Instruments 10.4.1.1. Automated Broth Microdilution Systems 10.4.1.2. Manual Broth Microdilution Systems 10.4.1.3. Semi-Automated Broth Microdilution Systems 10.4.2. Software & Services 10.4.2.1. Image Analysis Software 10.4.2.2. Installation Services 10.4.3. Kits & Reagents 10.5. Market Size Forecast By Product Type, 2022–2028 10.6. Historical Market Size Forecast By Application, 2022–2028 10.6.1. Sepsis 10.6.2. Respiratory Infections 10.6.3. Gastrointestinal Infections 10.6.4. Meningitis & Encephalitis 10.6.5. Endocarditis 10.6.6. Others 10.7. Market Size Forecast By Application, 2022–2028 10.8. Historical Market Size Forecast By End User, 2022–2028 10.8.1. Diagnostic Laboratories 10.8.2. Hospitals 10.8.3. Research Laboratories 10.9. Market Size Forecast By End User, 2022–2028 10.10. Market Attractiveness Analysis 10.10.1. By Country 10.10.2. By Product Type 10.10.3. By Application 10.10.4. By End User 11. Middle East and Africa Market Analysis 2013-2021 and Forecast 2022–2028 11.1. Introduction 11.2. Historical Market Size Analysis By Country, 2013-2021 11.2.1. South Africa 11.2.2. Saudi Arabia 11.2.3. Rest of Middle East and Africa 11.3. Market Size Forecast By Country, 2022–2028 11.4. Historical Market Size Forecast By Product Type, 2022–2028 11.4.1. Instruments 11.4.1.1. Automated Broth Microdilution Systems 11.4.1.2. Manual Broth Microdilution Systems 11.4.1.3. Semi-Automated Broth Microdilution Systems 11.4.2. Software & Services 11.4.2.1. Image Analysis Software 11.4.2.2. Installation Services 11.4.3. Kits & Reagents 11.5. Market Size Forecast By Product Type, 2022–2028 11.6. Historical Market Size Forecast By Application, 2022–2028 11.6.1. Sepsis 11.6.2. Respiratory Infections 11.6.3. Gastrointestinal Infections 11.6.4. Meningitis & Encephalitis 11.6.5. Endocarditis 11.6.6. Others 11.7. Market Size Forecast By Application, 2022–2028 11.8. Historical Market Size Forecast By End User, 2022–2028 11.8.1. Diagnostic Laboratories 11.8.2. Hospitals 11.8.3. Research Laboratories 11.9. Market Size Forecast By End User, 2022–2028 11.10. Market Attractiveness Analysis 11.10.1. By Country 11.10.2. By Product Type 11.10.3. By Application 11.10.4. By End User 12. Forecast Factors: Relevance and Impact 13. Forecast Assumptions 14. Market Structure Analysis 14.1. Market Structure by Tier 14.2. Market Share Analysis (2021) for Top Players, By Region 15. Competition Analysis 15.1. Competition Dashboard 15.2. Company Profiles 15.2.1. BD 15.2.1.1. Overview 15.2.1.2. Product Portfolio 15.2.1.3. Key Financials 15.2.1.4. SWOT Analysis 15.2.1.5. Marketing Strategy 15.2.2. Thermo Fischer Scientific Inc. 15.2.2.1. Overview 15.2.2.2. Product Portfolio 15.2.2.3. Key Financials 15.2.2.4. SWOT Analysis 15.2.2.5. Marketing Strategy 15.2.3. bioMérieux SA 15.2.3.1. Overview 15.2.3.2. Product Portfolio 15.2.3.3. Key Financials 15.2.3.4. SWOT Analysis 15.2.3.5. Marketing Strategy 15.2.4. Bio-Rad Laboratories Inc. 15.2.4.1. Overview 15.2.4.2. Product Portfolio 15.2.4.3. Key Financials 15.2.4.4. SWOT Analysis 15.2.4.5. Marketing Strategy 15.2.5. Merck KGaA 15.2.5.1. Overview 15.2.5.2. Product Portfolio 15.2.5.3. Key Financials 15.2.5.4. SWOT Analysis 15.2.5.5. Marketing Strategy 15.2.6. Creative Diagnostics 15.2.6.1. Overview 15.2.6.2. Product Portfolio 15.2.6.3. Key Financials 15.2.6.4. SWOT Analysis 15.2.6.5. Marketing Strategy 15.2.7. Danaher Corporation 15.2.7.1. Overview 15.2.7.2. Product Portfolio 15.2.7.3. Key Financials 15.2.7.4. SWOT Analysis 15.2.7.5. Marketing Strategy 15.2.8. Accelerate Diagnostics, Inc. 15.2.8.1. Overview 15.2.8.2. Product Portfolio 15.2.8.3. Key Financials 15.2.8.4. SWOT Analysis 15.2.8.5. Marketing Strategy 16. Global Market Analysis 2013-2021 and Forecast 2022–2028 By Region 16.1. Introduction / Key Findings 16.2. Historical Market Size Analysis By Region 16.2.1. North America 16.2.2. Latin America 16.2.3. Europe 16.2.4. Asia-Pacific and China 16.2.5. Middle East and Africa 16.3. Market Size Forecast By Region 16.4. Market Attractiveness Analysis By Region 17. Global Market Analysis 2013-2021 and Forecast 2022–2028, By Product Type 17.1. Introduction/Key Finding 17.2. Historical Market Size Analysis By Product Type, 2013-2021 17.2.1. Instruments 17.2.1.1. Automated Broth Microdilution Systems 17.2.1.2. Manual Broth Microdilution Systems 17.2.1.3. Semi-Automated Broth Microdilution Systems 17.2.2. Software & Services 17.2.2.1. Image Analysis Software 17.2.2.2. Installation Services 17.2.3. Kits & Reagents 17.3. Market Size Forecast By Product Type, 2022–2028 17.4. Market Attractiveness Analysis By Product Type 18. Global Market Analysis 2013-2021 and Forecast 2022–2028, By End User 18.1. Introduction/Key Finding 18.2. Historical Market Size Analysis By End User, 2013-2021 18.2.1. Diagnostic Laboratories 18.2.2. Hospitals 18.2.3. Research Laboratories 18.3. Market Size Forecast By End User, 2022–2028 18.4. Market Attractiveness Analysis By End User 19. Global Market Analysis 2013-2021 and Forecast 2022–2028 19.1. Market Value Share Analysis By All Segment 19.2. Y-o-Y Growth Analysis By All Segment 19.3. Absolute $ Opportunity 20. Assumptions and Acronyms Used 21. Research Methodology
Healthcare
October 2020
REP-GB-12575
June 2023
220 pages
Healthcare
February 2021
REP-GB-13025
June 2023
273 pages
Explore Healthcare Insights
View Reports
Antibiotic Susceptibility Testing Market
